|
TW202038909A
|
|
Polymer micelle carrier composition and medicine-containing polymer micelle composition
|
|
US2018153920A1
|
|
Unit structure-type pharmaceutical composition for nucleic acid delivery
|
|
WO2017170846A1
|
|
Pharmaceutical polymer micelle composition
|
|
TW201737946A
|
|
Drug-conjugated block copolymer, block copolymer, and method for producing drug-conjugated block copolymer
|
|
EP3329925A1
|
|
Polyion complex capable of delivering mrna into living body for treating arthropathy
|
|
CN107249565A
|
|
Polymer micelle carrier compositions and polymer micelle composition
|
|
WO2016137007A1
|
|
Polymer treatment agent
|
|
AU2015264793A1
|
|
Particulate medicinal composition
|
|
SG11201509460UA
|
|
Polymeric micelle pharmaceutical composition
|
|
CA2828700A1
|
|
Pharmaceutical composition containing block copolymer comprising boronic acid compound
|
|
EP2474306A1
|
|
Particle composition and medicinal composition comprising same
|
|
CN101808668A
|
|
Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
|
|
CA2724821A1
|
|
Polymer derivative of docetaxel, method of preparing the same and uses thereof
|
|
CA2666697A1
|
|
Block copolymer for drug conjugates and pharmaceutical composition
|
|
WO2008026776A1
|
|
Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient
|
|
WO2007136134A1
|
|
Process for producing polymer micelle enclosing hydrophobic drug
|
|
KR20090031568A
|
|
Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle
|
|
EP2011516A1
|
|
Method of producing polymer micelle having low molecular chemical encapsulated therein
|
|
KR20080106219A
|
|
Stabilizer for hydrophobic compounds
|
|
WO2007066781A1
|
|
Process for producing pharmaceutical composition containing drug-encapsulating polymer micelle using fluorine-containing organic solvent
|
